Microfactories-Bioproduction of Chemicals and Pharmaceuticals by using Microbes
Asian Journal of Biology,
A variety of organisms, such as bacteria, fungi, and plants, produce secondary metabolites, also known as natural products. Natural products have been a prolific source and an inspiration for numerous medical agents with widely divergent chemical structures and biological activities, including antimicrobial, immunosuppressive, anticancer, and anti-inflammatory activities, many of which have been developed as treatments and have potential therapeutic applications for human diseases. Aside from natural products, the recent development of recombinant DNA technology has sparked the development of a wide array of biopharmaceutical products, such as recombinant proteins, offering significant advances in treating a broad spectrum of medical illnesses and conditions. Fine chemicals that are physiologically active, such as pharmaceuticals, cosmetics, nutritional supplements, flavoring agents as well as additives for foods, feed, and fertilizer are produced by enzymatically or through microbial fermentation. The identification of enzymes that catalyze the target reaction makes possible to synthesis of the desired fine chemical. The genes encoding these enzymes are then introduced into suitable microbial hosts that are cultured with inexpensive, naturally abundant carbon sources, and other nutrients. Metabolic engineering create efficient microbial cell factories for producing chemicals at higher yields. In the present review, we summarize recent studies on bio-based fine chemical production and assess the potential of synthetic bioengineering for further improvement their productivity.
- Antimicrobial assay
- microbial cell factories
- Metabolic engineering
- biopharmaceutical products
How to Cite
Ahmadi MK, Pfeifer BA. Improved heterologous production of the nonribosomal peptide-polyketide siderophore yersiniabactin through metabolic engineering and induction optimization. Biotechnol. Prog. 2016;32:1412–1417.
Anné J, Maldonado B, Van Impe J, Van Mellaert L, Bernaerts K. Recombinant protein production and streptomycetes. J. Biotechnol. 2012;158:159–167.
Legaz ME, Vicente C, de Armas R. Bioproduction of depsidones for pharmaceutical purposes. INTECH Open Access Publisher; 2011.
Mitsui R, Yamada R, Ogino H. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals. World Journal of Microbiology and Biotechnology. 2019;35(7):1-9.
Bellini AV, Galli G, Fascetti E, Frascotti G, Branduzzi P, Lucchese G, et al. Production processes of recombinant IL-1β from Bacillus subtilis: Comparison between intracellular and exocellular expression. J. Biotechnol. 1991;18:177–192.
Breyner NM, Michon C, De Sousa CS, Vilas Boas PB, Chain F, Azevedo VA, et al. Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-kappaB pathway. Front. Microbiol. 2017;8:114.
Johnson ET, Schmidt-Dannert C. Light-energy conversion in engineered microorganisms. Trends Biotechnol. 2008;26:682–689.
Fonda ML. L-glutamate decarboxylase from bacteria. Methods Enzymol. 1985;113:11–16.
Komatsuzaki N, Kawamoto S, Momose H, Kimura T, Shima J. Production of gamma-aminobutyric acid (GABA) by Lactobacillus paracasei isolated from traditional fermented foods. Food Microbiol. 2005;22:497–504.
Li HX, Qiu T, Gao DD, Cao YS. Medium optimization for production of gamma-aminobutyric acid by Lactobacillus brevis NCL912. Amino Acids. 2010;38:1439–1445.
Park SJ, Kim EY, Noh W, Oh YH, Kim HY, Song BK, et al. Synthesis of nylon 4 from gamma-aminobutyrate (GABA) produced by recombinant Escherichia coli. Bioprocess Biosyst Eng 2013;36:885–892.
Shi F, Li Y. Synthesis of gamma-aminobutyric acid by expressing Lactobacillus brevis-derived glutamate decarboxylase in the Corynebacterium glutamicum strain ATCC 13032. Biotechnol Lett. 2011;33:2469–2474.
Chandra Mohana N, Yashavantha Rao HC, Rakshith D, Mithun PR, Nuthan BR, Satish S. Omics based approach for biodiscovery of microbial natural products in antibiotic resistance era. J. Genet. Eng. Biotechnol. 2018;16:1–8.
Dasgupta A. Advances in antibiotic measurement. Adv. Clin. Chem. 2012;56:75–104.
De Mey M, Lequeux GJ, Beauprez JJ, Maertens J, Waegeman HJ, Van Bogaert IN, et al. Transient metabolic modeling of Escherichia coli MG1655 and MG1655 deltaackA-pta, deltapoxB deltapppc ppc-p37 for recombinant beta-galactosidase production. J. Ind. Microbiol. Biotechnol. 2010;37:793–803.
Cankar K, van Houweligen A, Bosch D, Sonke T, Bouwmeester H, Beekwilder J. A chicory cytochrome P450 mono-oxygenase CYP71AV8 for the oxidation of (+)-valencen. FEBS Lett 2011;585:178–182.
Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol. 2003;21:796–802.
Fossati E, Ekins A, Narcross L, Zhu Y, Falgueyret JP, Beaudoin GA, Facchini PJ, Martin VJ. Reconstitution of a 10-gene pathway for synthesis of the plant alkaloid dihydrosanguinarine in Saccharomyces cerevisiae. Nat Commun. 2014;5:3283.
Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr. 2004;145:297–303.
Deleu M, Paquot M, Nylander T. Effect of fengycin, a lipopeptide produced by Bacillus subtilis, on model biomembranes. Biophys. J. 2008;94:2667–2679.
Harvey CJB, Tang M, Schlecht U, Horecka J, Fischer CR, Lin HC, et al. HEx: a heterologous expression platform for the discovery of fungal natural products. Sci. Adv. 4:eaar5459; 2018.
Heijtink RA, Bergen PV, Melber K, Janowicz ZA, Osterhaus AD. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination. Vaccine. 2002;20: 2191–2196.
Hercus TR, Barry EF, Dottore M, Mcclure BJ, Webb AI, Lopez AF, et al. High yield production of a soluble human interleukin-3 variant from E. coli with wild-type bioactivity and improved radiolabeling properties. PLoS One. 2013;8:e74376.
Hou J, Tyo K, Liu Z, Petranovic D, Nielsen J. Engineering of vesicle trafficking improves heterologous protein secretion in Saccharomyces cerevisiae. Metab. Eng. 2012;14:120–127.
Jozala AF, Geraldes DC, Tundisi LL, Feitosa VA, Breyer CA, Cardoso SL, et al. Biopharmaceuticals from microorganisms: From production to purification. Braz. J. Microbiol. 2016;47:51–63.
Kim EJ, Yang I, Yoon YJ. Developing Streptomyces venezuelae as a cell factory for the production of small molecules used in drug discovery. Arch. Pharm. Res. 2015;38:1606–1616.
Kim YH, Park BS, Bhatia SK, Seo HM, Jeon JM, Kim HJ, et al. Production of rapamycin in Streptomyces hygroscopicus from glycerol-based media optimized by systemic methodology. J. Microbiol. Biotechnol. 2014;24:1319–1326.
McDaniel R, Licari P, Khosla C. Process development and metabolic engineering for the overproduction of natural and unnatural polyketides. Adv. Biochem. Eng. Biotechnol. 2001;73:31–52.
McDaniel R, Thamchaipenet A, Gustafsson C, Fu H, Betlach M, Ashley G. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel ”unnatural” natural products. Proc. Natl. Acad. Sci. U.S.A. 1999;96:1846–1851.
McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, et al. Ilotycin, a new antibiotic. Antibiot. Chemother. (Northfield). 1952;2:281–283.
Medema MH, Fischbach MA. Computational approaches to natural product discovery. Nat. Chem. Biol. 2015;11:639–648.
Meehl MA, Stadheim TA. Biopharmaceutical discovery and production in yeast. Curr. Opin. Biotechnol. 2014;30:120–127.
Metsä-Ketelä M, Niemi J, Mäntsälä P, Schneider G. “Anthracycline biosynthesis: Genes, enzymes and mechanisms,” in Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry, ed. K. Krohn (Berlin: Springer). 2008;101–140.
Meyer V, Wu B, Ram AFJ. Aspergillus as a multi-purpose cell factory: Current status and perspectives. Biotechnol. Lett. 2011;33:469–476.
Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl. Microbiol. Biotechnol. 2005;68:705–717.
Migita K, Eguchi K. FK506: Anti-inflammatory properties. Curr. Med. Chem. 2003;2:5.
Miller GH, Arcieri G, Weinstein MJ, Waitz JA. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob. Agents Chemother. 1976;10:827–836.
Mo S, Ban YH, Park JW, Yoo YJ, Yoon YJ. Enhanced FK506 production in Streptomyces clavuligerus CKD1119 by engineering the supply of methylmalonyl-CoA precursor. J. Ind. Microbiol. Biotechnol. 2009;36:1473–1482.
Mo S, Yoo YJ, Ban YH, Lee SK, Kim E, Suh JW, et al. Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP. Appl. Environ. Microbiol. 2012;78:2249–2255.
Moazed D, Noller HF. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature. 1987;327:389–394.
Molnar I, Schupp T, Ono M, Zirkle R, Milnamow M, Nowak-Thompson B, et al. The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem. Biol. 2000;7: 97–109.
Morello E, Bermudez-Humaran LG, Llull D, Sole V, Miraglio N, Langella P, et al. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J. Mol. Microbiol. Biotechnol. 2008;14:48–58.
Moses T, Pollier J, Almagro L, Buyst D, Van Montagu M, Pedreño M.A, et al. Combinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16α hydroxylase from Bupleurum falcatum. Proc. Natl. Acad. Sci. U.S.A. 2014;111:1634–1639.
Müller F, Tieke A, Waschk D, Mühle C, Müller F, Seigelchifer M, et al. Production of IFNα-2a in Hansenula polymorpha. Process Biochem. 2002;38:15–25.
Müller S, Sandal T, Kamp-Hansen P, Dalbøge H. Comparison of expression systems in the yeasts Saccharomyces cerevisiae, Hansenula polymorpha, Klyveromyces lactis, Schizosaccharomyces pombe and Yarrowia lipolytica. Cloning of two novel promoters from Yarrowia lipolytica. Yeast. 1998;14:1267–1283.
Murakami T, Burian J, Yanai K, Bibb MJ, Thompson CJ. A system for the targeted amplification of bacterial gene clusters multiplies antibiotic yield in Streptomyces coelicolor. Proc. Natl. Acad. Sci. U.S.A. 2011;108:16020–16025.
Mutka SC, Bondi SM, Carney JR, Da Silva NA, Kealey JT. Metabolic pathway engineering for complex polyketide biosynthesis in Saccharomyces cerevisiae. FEMS Yeast Res. 2006;6:40–47.
Nakashima N, Mitani Y, Tamura T. Actinomycetes as host cells for production of recombinant proteins. Microb. Cell Fact. 2005;4:7.
Nandy SK, Srivastava RK. A review on sustainable yeast biotechnological processes and applications. Microbiol. Res. 2018;207:83–90.
Nannemann DP, Birmingham WR, Scism RA, Bachmann BO. Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis. Future Med. Chem. 2011;3:809–819.
DOI: 10.4155/fmc. 11.48
Abstract View: 73 times
PDF Download: 48 times